The shortage of essential chemotherapy drugs in the United States.

Some essential oncology drugs are in short supply in the United States, raising concern about safety, cost, and availability of life-saving treatments. The causes are economic: manufacturers don't make big profits on generics, and oncologists make money on drug markups.